USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	021336/0565			Pages:	9
		Recorded:	08/04/2008
Attorney Dkt #:	GENZYME ASSIGNMENT
Conveyance:	ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 11

Patent #:	7888324	Issue Dt:	02/15/2011	Application #:	09920033	Filing Dt:	08/01/2001
Publication #:	US20030087853	Pub Dt:	05/08/2003
Title:	ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION

Patent #:	7407943	Issue Dt:	08/05/2008	Application #:	10147196	Filing Dt:	05/15/2002
Publication #:	US20030215943	Pub Dt:	11/20/2003
Title:	ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION

Patent #:	7511131	Issue Dt:	03/31/2009	Application #:	10712795	Filing Dt:	11/13/2003
Publication #:	US20040214325	Pub Dt:	10/28/2004
Title:	ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION

Patent #:	7803930	Issue Dt:	09/28/2010	Application #:	10920612	Filing Dt:	08/17/2004
Publication #:	US20050009088	Pub Dt:	01/13/2005
Title:	ANTISENSE MODULATION OF APOLIPOPROTEIN B-EXPRESSION

Patent #:	NONE	Issue Dt:		Application #:	11123656	Filing Dt:	05/05/2005
Publication #:	US20060009410	Pub Dt:	01/12/2006
Title:	Effects of apolipoprotein B inhibition on gene expression profiles in animals

Patent #:	NONE	Issue Dt:		Application #:	11124020	Filing Dt:	05/05/2005
Publication #:	US20050287558	Pub Dt:	12/29/2005
Title:	SNPs of apolipoprotein B and modulation of their expression

Patent #:	NONE	Issue Dt:		Application #:	11200710	Filing Dt:	08/10/2005
Publication #:	US20060035858	Pub Dt:	02/16/2006
Title:	Methods for modulating lipoprotein and cholesterol levels in humans

Patent #:	NONE	Issue Dt:		Application #:	11573537	Filing Dt:	08/27/2009
Publication #:	US20090326040	Pub Dt:	12/31/2009
Title:	ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION

Patent #:	NONE	Issue Dt:		Application #:	11573537	Filing Dt:	08/27/2009
Publication #:	US20090326040	Pub Dt:	12/31/2009			PCT #:	US0528342
Title:	ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION

Patent #:	8735364	Issue Dt:	05/27/2014	Application #:	11969096	Filing Dt:	01/03/2008
Publication #:	US20080242629	Pub Dt:	10/02/2008
Title:	ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION

Patent #:	9347061	Issue Dt:	05/24/2016	Application #:	12532602	Filing Dt:	04/30/2010
Publication #:	US20100297105	Pub Dt:	11/25/2010			PCT #:	US0858072
Title:	ADMINISTERING ANTISENSE OLIGONUCLEOTIDES COMPLEMENTARY TO HUMAN APOLIPOPROTEIN B

Assignor

Exec Dt:

07/17/2008

Assignee

500 KENDALL STREET

CAMBRIDGE, MASSACHUSETTS 02142

Correspondence name and address
	ISIS PHARMACEUTICALS, INC.
	1896 RUTHERFORD ROAD
	CARLSBAD, CA 92008

Search Results as of: 05/26/2024 12:13 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6